New Prospective Multicenter Long-Term Balloon Kyphoplasty Study to be Featured on American Health Radio
October 02 2006 - 8:00AM
PR Newswire (US)
SUNNYVALE, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Kyphon Inc.
(NASDAQ:KYPH) announced today that Richard Mott, Kyphon's president
and chief executive officer, and Dr. Rudolph Buckley, orthopaedic
spine surgeon from Slocum Dickson Medical Group in Utica, New York,
will be interviewed on American Health Radio, the
nationally-syndicated health radio program hosted by Scott Broder.
Dr. Buckley is co-author of the first-ever prospective multicenter
long-term clinical study evaluating the benefits of balloon
kyphoplasty treatment of osteoporotic spinal fractures. This study
was recently published in the September 1, 2006 issue of Spine, the
leading subspecialty, peer-reviewed journal reporting on spinal
disorders. The program will air live today, Monday, October 2, 2006
at 6:00 p.m. Central Time and can be accessed at
http://www.wrmn1410.com/. A replay of the program will be available
on Wednesday, October 4 at 8:00 p.m. Central Time and on Friday,
October 6 at 6:00 p.m. Central Time at
http://www.healthradionetwork.com/. This latest study in the
growing body of evidence for balloon kyphoplasty showed that
patients experienced rapid and sustained improvement in back pain,
back function and quality of life for two years post-procedure. In
addition, the study documented improvements in restoring vertebral
height and high patient satisfaction with the procedure. To view a
Multimedia News Release, which reveals details about the study,
please visit http://www.prnewswire.com/mnr/kyphon/25116. Spinal
Fractures and Balloon Kyphoplasty The majority of spinal fractures
are caused by osteoporosis, a progressive disease that causes bones
to become brittle, weak and susceptible to painful, debilitating
fractures. According to the National Osteoporosis Foundation,
one-in-two women and one-in-four men over the age of 50 in the U.S.
will experience a spinal fracture, with two-thirds going
undiagnosed. Cancer, including multiple myeloma and the metastasis
of other tumors to bone, can also affect bone quality and lead to
spinal fracture. In cases of multiple spinal fractures, a loss of
height and stooped posture -- known as kyphosis -- can occur, which
affects the ability to stand upright and walk, and can make simple
tasks like lifting a bag of groceries or getting dressed difficult.
Left untreated, each additional fracture increases future fracture
risk, accelerating the effects of the spinal deformity. Increasing
kyphosis is associated with decreased respiratory function, reduced
ability to walk, decreased quality of life, and an increased risk
of early mortality. Supplemental calcium with vitamin D and
prescription medications are often used to slow down bone loss and
treat the underlying osteoporosis. Medical management, however,
does not always prevent fracture. Despite the advances in drug
therapy, spinal fractures continue to occur and may require
surgical intervention. First performed in 1998, balloon kyphoplasty
is a minimally invasive procedure which can treat the fracture,
reduce pain, restore quality of life, and repair some or all of the
associated deformity. To date, over 275,000 spinal fractures have
been treated using balloon kyphoplasty worldwide. To request a full
copy of the study, go to
http://www.kyphon.com/professionals/pcpnewsletterrequests.cfm. To
find a Spine Specialist who performs Balloon Kyphoplasty in your
area, go to http://www.kyphon.com/phys_Locator.cfm. For additional
downloadable media materials, go to
http://www.kyphon.com/media.cfm. About Kyphon Inc. Kyphon develops
and markets medical devices designed to restore spinal function
using minimally invasive technologies. The company's KyphX line of
products is used in balloon kyphoplasty, a minimally invasive
procedure to treat spinal fractures caused by osteoporosis or
cancer. For more information, visit Kyphon's Web site at
http://www.kyphon.com/. Kyphon and KyphX are registered trademarks
of Kyphon Inc. KYPHG DATASOURCE: Kyphon Inc. CONTACT: Julie D.
Tracy, Vice President, Investor Relations and Corporate Marketing
of Kyphon Inc., +1-408-548-6500, Web site: http://www.kyphon.com/
http://www.wrmn1410.com/ http://www.healthradionetwork.com/
http://www.prnewswire.com/mnr/kyphon/25116
http://www.kyphon.com/professionals/pcpnewsletterrequests.cfm
http://www.kyphon.com/phys_Locator.cfm
http://www.kyphon.com/media.cfm
Copyright
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jul 2023 to Jul 2024